Executive Briefing - South of the border: the lure of Argentina and Mexico
This article was originally published in Scrip
Executive Summary
With the emerging market economies of Argentina, Brazil, China, India, Mexico and Russia growing at a faster rate than those of western countries, it is no surprise that they are drawing so much attention from numerous industries. Certainly, multinational pharma has awoken to the new opportunities offered by these markets, especially in the face of growing pressures in the US, Europe and Japan.
You may also be interested in...
ANALYSIS: Orphan disease specialists find a likely home in Big Pharma
Tumbling over the patent cliff, many big pharma companies are being forced to find new strategies for sustaining sales growth, wherever possible minimising the risk of generic competition.